Marta Bognar, MD
Rheumatology · Gainesville, GANPI 1336102425
Payments from drug & device makers
Across 1,384 payments — averaging $519.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$426K
- Eli Lilly$209K
- Pfizer$53K
- GSK$12K
- AbbVie$4K
- Amgen$3K
- plus $11K from 30 others
Across 11 payments — averaging $1054.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$10K
- GSK$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 247 | $426,437 |
| Eli Lilly | 14 | $209,254 |
| Pfizer | 86 | $52,574 |
| GSK | 43 | $12,394 |
| AbbVie | 268 | $4,371 |
| Amgen(2 entities) | 139 | $2,793 |
| Novartis | 163 | $2,712 |
| UCB, Inc. | 99 | $1,631 |
| Johnson & Johnson(2 entities) | 62 | $1,418 |
| E.r. Squibb & Sons, L.L.C. | 48 | $858 |
| Sanofi | 34 | $649 |
| Aurinia Pharma U.S., Inc. | 36 | $647 |
| AstraZeneca(2 entities) | 28 | $579 |
| Boehringer Ingelheim | 19 | $578 |
| Lilly USA, LLC | 24 | $420 |
| Radius Health, Inc. | 12 | $269 |
| Sobi, Inc | 13 | $238 |
| Sanofi-aventis U.S. LLC | 2 | $155 |
| Organon | 9 | $153 |
| Genentech USA, Inc. | 5 | $111 |
| Octapharma USA, Inc. | 5 | $98 |
| Bristol Myers Squibb | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $53 |
| Fresenius Kabi USA, LLC | 3 | $51 |
| Invivyd Inc | 2 | $39 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
| Boston Scientific | 1 | $31 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Merck | 1 | $14 |
| Medexus Pharma, Inc. | 1 | $12 |
How this compares
$718,848 in reported general payments places this provider in the 90th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Gainesville
- Brent FlickingerGainesville$1.6M
- William ChafinGainesville$18K
- Stephen ElmoreGainesville$18K
- Huma SohailGainesville$14K
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.